 Home > Medical News > Latest Medical News > AstraZeneca abandoned the new crown vaccine for beta variants and has entered clinical phase 2/3!

AstraZeneca abandoned the new crown vaccine for beta variants and has entered clinical phase 2/3!

 Last Update: 2022-03-08
 Source: Internet
 Author: User

Tags

manufacturing companies milwaukee

solid phase peptide synthesis

number 2 chain

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

CompilationAspirin

AstraZeneca's Covid-19 vaccine for the beta variant entered Phase 2/3 of clinical trials last year

Another important reason was that there was no significant difference between the immunogenicity of AZD2816 and Vaxzevria

For these two reasons, AstraZeneca will abandon the beta variant and stick with its first-generation vaccine, Vaxzevria

When the beta variant was discovered in October 2020, it represented the most worrying variant of the new coronavirus at the time from an immune escape perspective

Given the small genetic differences between the beta variant and the original SARS-CoV-2 virus, AstraZeneca responded by tweaking its first-generation Vaxzevria vaccine

AstraZeneca dosed the first subjects in a Phase 2/3 clinical trial in June 2021

The rise and fall of AZD2816 offers a cautionary tale for Moderna and Pfizer

AstraZeneca disclosed the termination of AZD2816 in its quarterly report, while revealing the removal of a series of early-stage projects from its pipeline

Reference article: AstraZeneca dumps late-phase, next-gen COVID-19 vaccine, calling time on a beta player in an omicron world

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.